Home/Directory/Contract Development & Manufacturing/ISOLOGIC Innovative Radiopharmaceuticals

ISOLOGIC Innovative Radiopharmaceuticals

Dorval, QC · Canada

Contract Development & Manufacturingmid

Specialization: Radiopharmaceutical CDMO, PET and SPECT isotopes

Key Differentiator

Runs a national network of radiopharmacies, PET sites and Class 7 transport for diagnostic radiotracers in Canada.

Core Services

Radiopharmaceutical CDMO; Cyclotron target irradiation; SPECT and PET dose preparation; Hospital radiopharmacy operation; Class 7 logistics; Canadian market entry

Capabilities

F 18 production from cyclotron liquid targetsGMP unit and bulk dose preparationOn site radiopharmacies at Ottawa and Vancouver General HospitalPET manufacturing at Sunnybrook and CHUMTransport Canada approved Class 7 shippingCold kit distribution and warehousingRegulatory and licensing support for market entry

Market Intelligence

Canadian company with head office in Dorval, Quebec. In June 2024 it announced a $29.9 million investment to expand its Lachine site and add an 18 MeV cyclotron, expected to run from Q1 2026.

Need help finding the right outsourcing partner?

Try AI Navigator

Company information is sourced from publicly available data and may not be current. PharmoniQ does not endorse any company listed. Contact companies directly for the most up-to-date information.